Velarion · Company Intelligence
Compensation Brief
Fiscal year 2025 · Filings through 2026-06-18

Sellas Life Sciences Group (SLS)

Fiscal year 2025 executive and director compensation, incentive-plan design, equity activity, and governance — every figure in this brief is traceable to its exact location in the company’s SEC filing — the document, the section, the page, and the table, linked directly.

$1,877,810
Angelos Stergiou total, FY2025
CEO pay percentile vs peers
CEO-to-median pay ratio
76.89%
Say-on-pay support, latest vote
Companies that benchmark against SLS
No companies currently name SLS as a compensation peer in their most recent disclosure.

This is the complete answer, not a partial one — the list is never padded.

01

Summary Compensation Table — fiscal year 2025

Named executive officerSalaryBonusStock awardsOption awardsNon-equity incentivePension / NQDCAll otherTotal
Angelos Stergiou$676,000$0$477,107$327,695$390,390$0$6,618$1,877,810
President and Chief Executive Officer
Dragan Cicic451,2340185,071143,990193,128018,372991,795
Senior Vice President, Chief Development Officer
John Burns429,6050185,071143,990185,589015,398959,653
Senior Vice President, Chief Financial Officer

A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed in the filing, without adjustment.

Three-year trend — total compensation per named executive

Named executive officerFY2025 totalFY2024 totalFY2023 totalΔ FY20242025
Angelos Stergiou$1,877,810
Dragan Cicic991,795
John Burns959,653

Prior-year totals as disclosed in the corresponding proxy; deltas are computed values with the derivation shown in the register.

02

Equity transactions since the proxy statement was filed

No insider equity transactions reported since the proxy statement.

04

Outstanding equity awards at fiscal year-end 2025

ExecutiveAwardShares unvestedExercise priceMarket value unvested
Dragan CicicOption33,8540.52
Angelos StergiouRSU192,750726,668
Angelos StergiouRSU95,000358,150
Dragan CicicRSU84,750319,508
John BurnsRSU84,750319,508
Angelos StergiouRSU79,500299,715
Dragan CicicRSU25,00094,250
John BurnsRSU23,50088,595
Dragan CicicRSU22,50084,825
John BurnsRSU15,00056,550
Angelos StergiouRSU14,50054,665
John BurnsRSU5,00018,850
Dragan CicicRSU4,00015,080
Angelos StergiouOption3,4385.34
Angelos StergiouOption63,4383.34
Angelos StergiouOption124,2190.52
Angelos StergiouOption385,7500.95
Dragan CicicOption1,0165.34
Dragan CicicOption16,0423.34
Dragan CicicOption169,5000.95
John BurnsOption7505.34
John BurnsOption21,8753.34
John BurnsOption39,0630.52
John BurnsOption169,5000.95
05

Incentive-plan design — the Compensation Discussion & Analysis

The Company's compensation program is designed to enable the Company to attract and retain talented and experienced executives capable of leading the Company successfully in a competitive environment, with a focus on pay-for-performance principles and alignment with stockholders' interests.

CEO STI target (% of salary)
CEO LTI target (% of salary)
Independent consultant
Clawback policytrue
Anti-hedging
Anti-pledging
06

Say-on-pay — recent advisory votes

Meeting yearMeeting dateForAgainstAbstainSupportOutcome
20262026-06-1652,930,79215,906,7322,196,65476.89%Passed
20252025-06-1729,589,24912,767,7911,128,17969.86%Passed
20242024-06-205,992,5104,808,398554,17555.48%Passed
20232023-06-204,772,5473,079,811135,40160.78%Passed
20222022-06-084,224,2921,575,97777,83472.83%Passed
20212021-06-082,383,795849,429200,41873.73%Passed

Rows are labeled by annual-meeting year, with the meeting date beside each; the vote held in a given year acts on the prior fiscal year's compensation.

Say-on-pay — history, company's computation

Meeting yearMeeting dateApproval — company's computation
20262026-06-1676.89%a
20252025-06-1769.86%b
20242024-06-2055.48%c

a. Voting standard not stated in the filing.

b. Voting standard not stated in the filing.

c. Voting standard not stated in the filing.

Approval percentages are the company's own reported computations under its own stated standard, not recomputed by Velarion. Where a company does not state a standard, none is assumed.

08

Director compensation — fiscal year 2025

DirectorCash feesStock awardsOption awardsNon-equity incentiveAll otherTotal
John VarianIndependent · Board Chair · Audit · Compensation$94,000$11,906$15,011$120,917
Robert L. Van NostrandIndependent · Compensation · Audit · Nominating and Corporate Governance66,00011,90615,01192,917
Jane WasmanIndependent · Board (Chair) · Nominating and Corporate Governance (Chair) · Compensation · Audit66,00011,90615,01192,917
Katherine Bach KalinIndependent · Compensation · Nominating and Corporate Governance66,00011,90615,01192,917
David A. ScheinbergIndependent · Compensation · Science (Chair)66,00011,90615,01192,917
Angelos M. StergiouEmployee director · Science0
09

Board fee structure and ownership guideline

Annual cash retainer$40,000
Annual equity retainer
Per board meeting fee
Committee chair fees (audit / comp / nom-gov)18,000 / 18,000 / 18,000
Stock ownership guideline
09b

Total cost of the board

ComponentFY2025
Cash retainers and fees$358,000
Equity awards (grant-date value)$59,530
All other compensation$0
Total cost of the board$417,530

Computed as the sum of the director compensation table rows above; inputs and formula shown in the register.

10

Disclosed peer group — fiscal year 2025

The compensation peer group as the company disclosed it in its own proxy — the reference set behind the percentile above.

RadfordBYSI BeyondSpring Inc.
10a

Peer reciprocity

Of the companies Sellas Life Sciences Group names as compensation peers, which name it back in their own disclosed peer groups. A peer set the market reciprocates reads differently from one selected in a single direction.

BeyondSpring Inc. (BYSI)

Reciprocity shown where the peer's own current proxy has been read — each mark is cited in the register to that peer's filing. A dash means the peer's current proxy was read and names no reciprocal group including Sellas Life Sciences Group.

10b

Chief executive pay against the peer group

Most recent fiscal-year chief executive compensation at each disclosed peer, taken from that company's own proxy statement.

RankCompanyFYChief executiveSalaryStock awardsOption awardsNon-equity incentiveTotal
1Sellas Life Sciences Group2025Angelos Stergiou$676,000$477,107$327,695$390,390$1,877,810
BeyondSpring Inc.not in coverage universe

Each peer's compensation is from its most recently filed proxy; fiscal years differ by company. Each peer's figures come from its own filings; the subject company is highlighted. Peers whose chief executive compensation is outside our coverage universe are stated as such, never left blank.

10c

Incentive design against the same peers

CompanyAnnual incentive payoutLong-term vehicle mixPSU measures include TSRCompensation consultant
Sellas Life Sciences Groupnot disclosednot disclosednot disclosednot disclosed
BeyondSpring Inc.not disclosednot disclosednot disclosednot disclosed

Read from each company's Compensation Discussion and Analysis: annual incentive payout as a percentage of target, the disclosed long-term vehicle mix, whether performance-share measures include a total shareholder return component, and the retained compensation consultant. “Not disclosed” appears only where the company's filing does not state the item.

11

Source register

Each figure's location is given both for the eye (section · page · table · row · column) and for a script (table/row/column index and exact character span in the filed document). Any figure can be independently confirmed against the source.

#SupportsDocumentFiledAccessionLocation in document
1Section 01, Angelos StergiouDEF 14A2026-04-230001104659-26-047693Section “Summary Compensation Table”. As printed: 1,877,810. Filing ↗
2Section 01, Dragan CicicDEF 14A2026-04-230001104659-26-047693Section “Summary Compensation Table”. As printed: 991,795. Filing ↗
3Section 01, John BurnsDEF 14A2026-04-230001104659-26-047693Section “Summary Compensation Table”. As printed: 959,653. Filing ↗
4Section 08, John VarianDEF 14A2026-04-230001104659-26-047693Section “Director Compensation”. As printed: 120,917. Filing ↗machine: span 652056–652063
5Section 08, Robert L. Van NostrandDEF 14A2026-04-230001104659-26-047693Section “Director Compensation”. As printed: 92,917. Filing ↗machine: span 654631–654637
6Section 08, Jane WasmanDEF 14A2026-04-230001104659-26-047693Section “Director Compensation”. As printed: 92,917. Filing ↗machine: span 657219–657225
7Section 08, Katherine Bach KalinDEF 14A2026-04-230001104659-26-047693Section “Director Compensation”. As printed: 92,917. Filing ↗machine: span 662387–662393
8Section 08, David A. ScheinbergDEF 14A2026-04-230001104659-26-047693Section “Director Compensation”. As printed: 92,917. Filing ↗machine: span 659790–659796
9Section 08, Angelos M. StergiouDEF 14A2026-04-230001104659-26-047693Section “Director Compensation”. As printed: 0. Filing ↗
10Section 06, 2026 voteForm 8-K2026-06-180001104659-26-075775Item 5.07 · say-on-pay result. As reported: 76.89% (votes for as printed: 52,930,792). Filing ↗
11Section 06, 2025 voteForm 8-K2025-06-180001104659-25-060704Item 5.07 · say-on-pay result. As reported: 69.86% (votes for as printed: 29,589,249). Filing ↗
12Section 06, 2024 voteForm 8-K2024-06-210001104659-24-073957Item 5.07 · say-on-pay result. As reported: 55.48% (votes for as printed: 5,992,510). Filing ↗
13Section 09b board cost (computed)ComputedcomputedCash 358,000 + equity 59,530 + all other 0 = 417,530, summed across the director compensation table rows.machine: formula: Σ = 417,530
14Sellas Life Sciences Group (subject), Section 10b CEO totalDEF 14A2026-04-230001104659-26-047693CEO total compensation as printed in Sellas Life Sciences Group's own proxy. As printed: 1,877,810. Filing ↗